Literature DB >> 22770846

Determination of amlodipine in human plasma using automated online solid-phase extraction HPLC-tandem mass spectrometry: application to a bioequivalence study of Chinese volunteers.

Jianzhong Shentu1, Lizhi Fu, Huili Zhou, Xing Jiang Hu, Jian Liu, Junchun Chen, Guolan Wu.   

Abstract

An automated method (XLC-MS/MS) that uses online solid-phase extraction coupled with HPLC-tandem mass spectrometry was reported here for the first time to quantify amlodipine in human plasma. Automated pre-purification of plasma was performed using 10 mm × 2 mm HySphere C8 EC-SE online solid-phase extraction cartridges. After being eluted from the cartridge, the analyte and the internal standard were separated by HPLC and detected by tandem mass spectrometry. Mass spectrometric detection was achieved in the multiple reaction monitoring mode using a quadrupole tandem mass spectrometer in the positive electrospray ionization mode. The XLC-MS/MS method was validated and yielded excellent specificity. The calibration curve ranged from 0.10 to 10.22 ng/mL, and both the intra- and inter-day precision and accuracy values were within 8%. This method proved to be less laborious and was faster per analysis (high-throughput) than offline sample preparation methods. This method has been successfully applied in clinical pharmacokinetic and bioequivalence analyses.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22770846     DOI: 10.1016/j.jpba.2012.06.014

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

Review 1.  Clinical use of azelnidipine in the treatment of hypertension in Chinese patients.

Authors:  Bi-Lian Chen; Yin-Zhuang Zhang; Jian-Quan Luo; Wei Zhang
Journal:  Ther Clin Risk Manag       Date:  2015-02-24       Impact factor: 2.423

2.  Application of an LC-MS/MS method for the analysis of amlodipine, valsartan and hydrochlorothiazide in polypill for a bioequivalence study.

Authors:  Jaivik V Shah; Jignesh M Parekh; Priyanka A Shah; Priya V Shah; Mallika Sanyal; Pranav S Shrivastav
Journal:  J Pharm Anal       Date:  2017-06-04

3.  Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects.

Authors:  Minkyung Oh; Jong-Lyul Ghim; Sung-Eun Park; Eun-Young Kim; Jae-Gook Shin
Journal:  Drug Des Devel Ther       Date:  2018-05-08       Impact factor: 4.162

4.  Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study.

Authors:  Xin Li; Chenjing Wang; Ting Li; Yanping Liu; Shuqin Liu; Ye Tao; Yaping Ma; Xiaomeng Gao; Yu Cao
Journal:  BMC Pharmacol Toxicol       Date:  2020-11-19       Impact factor: 2.483

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.